C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 473/18 (2006.01) A61K 31/52 (2006.01) A61P 31/12 (2006.01) A61P 31/18 (2006.01) A61P 31/22 (2006.01) C07D 473/00 (2006.01) C07D 473/32 (2006.01)
Patent
CA 2238516
Compounds of formula (I) where one of R1 and R2 is - C(O)CH(CH(CH3)2)NH2 or -C(O)CH(CH(CH3)CH2CH3)NH2; the other of R1 and R2 is -C(~O)C3-C21 saturated or monounsaturated, optionally substituted alkyl; and R3 is OH or H; and pharmaceutically acceptable salts thereof have utility as enhanced bioavailability antivirals against herpes and retroviral infections.
On décrit des composés de la formule (I) dans laquelle R1 ou R2 correspond à -C(O)CH(CH(CH3)2)NH2 ou -C(O)CH(CH(CH3)CH2CH3)NH2, tandis que l'autre élément correspond à un alkyle -C(=O)C3-C21 facultativement substitué, saturé ou monoinsaturé, et R3 correspond à OH ou H. On décrit également des sels pharmaceutiquement acceptables de ces composés, utiles comme antiviraux, à biodisponibilité renforcée, contre l'herpès et les infections par rétrovirus.
Engelhardt Per
Hogberg Marita
Johansson Nils Gunnar
Lindborg Bjorn
Zhou Xiao-Xiong
Gowling Lafleur Henderson Llp
Medivir Ab
LandOfFree
Acyclic nucleoside derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acyclic nucleoside derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyclic nucleoside derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2027883